Menorrhagia clinical trials
9 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
- Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
- Delivering tAN to Reduce HMB: The LUNA Study
- A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
- Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
- Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
- Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Menorrhagia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.